Language selection

Search

Details for: INVEGA TRINZA

Company: JANSSEN INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02455943INVEGA TRINZAPALIPERIDONE (PALIPERIDONE PALMITATE)175 MG / 0.875 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
02455986INVEGA TRINZAPALIPERIDONE (PALIPERIDONE PALMITATE)263 MG / 1.315 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
02455994INVEGA TRINZAPALIPERIDONE (PALIPERIDONE PALMITATE)350 MG / 1.75 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
02456001INVEGA TRINZAPALIPERIDONE (PALIPERIDONE PALMITATE)525 MG / 2.625 MLSUSPENSION (EXTENDED-RELEASE)INTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: